1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Cytokinetics, Incorporated

Cytokinetics, Incorporated

61.23
USD
-1.10
(-1.76%)
-7.18EPS
11.82BMarket Cap
Nov 04Next Earn

Latest Stock Split

Jun 25, 2013

1:6

For every 6 shares held, investors received 1. The price per share adjusted from $2.05 to $12.30.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Jun 25, 2013
    Before$2.05
    Split ratio1:6
    After$12.30
    Reverse

About Cytokinetics, Incorporated stock splits

Cytokinetics, Incorporated (NASDAQ:CYTK) operates in the Pharmaceuticals: major industry.

Cytokinetics, Incorporated company overview

When did Cytokinetics, Incorporated stock split?

Cytokinetics, Incorporated's most recent stock split was on June 25, 2013. It was a 1-for-6 reverse split, so shareholders received 1 share for every 6 they held.

How many times has Cytokinetics, Incorporated stock split?

Cytokinetics, Incorporated has split its stock once. This history records one reverse split, on June 25, 2013.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Cytokinetics, Incorporated's 1-for-6 reverse split on June 25, 2013, every 6 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Cytokinetics, Incorporated split its stock again?

Cytokinetics, Incorporated has not announced a new split in our records. Its most recent split was on June 25, 2013, 13 years ago. Companies announce splits in advance, and any new NASDAQ:CYTK split will appear on this page.